Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2015-08-27 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于证券事务代表调整的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of the company's securities affairs representative, including details about the outgoing and incoming representatives. It is issued by the company's board and contains no financial data, report content, or regulatory filings beyond the personnel change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management or board members.
2015-08-27 Chinese
七届二十二次监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of Kunming Pharmaceutical Group Co., Ltd. It mentions the approval of the company's 2015 semi-annual report and a special report on the use of raised funds. The document is short (579 characters) and serves as an announcement of the supervisory board's meeting resolutions rather than the full semi-annual report itself. It does not contain detailed financial statements or substantive financial data. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as it is a formal announcement of meeting resolutions and approvals related to reports.
2015-08-27 Chinese
七届四十六次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Kunming Pharmaceutical Group Co., Ltd. It details the decisions made at the 46th meeting of the 7th board, including approval of the 2015 semi-annual report and a special report on the use of raised funds, as well as a change in the company's securities affairs representative. The document is short (712 characters) and primarily announces board decisions rather than providing the full semi-annual report or detailed financial data. It does not contain actual financial statements or substantive financial analysis, so it is not an Interim/Quarterly Report (IR). Instead, it is a Board/Management Information announcement about board resolutions and management changes. Therefore, the appropriate classification is MANG (Board/Management Information).
2015-08-27 Chinese
2015年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2015 年半年度报告' which translates to '2015 Half-Year Report'. It contains detailed financial data including income, profit, cash flow, and segment analysis for the first half of 2015. It includes sections such as company overview, financial data and indicators, board report, investment analysis, and detailed financial statements. The document is comprehensive and contains actual financial statements and substantive financial data for a period shorter than a full fiscal year (half-year). It is not a brief announcement or a certification letter but a full interim financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2015
2015-08-27 Chinese
2015年上半年募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2015 年上半年募集资金存放与实际使用情况的专项报告" which translates to a special report on the storage and actual use of raised funds for the first half of 2015. It details the use of funds raised through stock issuance, including amounts raised, usage, investment projects, and returns on investment. It references regulatory requirements from the China Securities Regulatory Commission and Shanghai Stock Exchange regarding the management and reporting of raised funds. The document is comprehensive, over 12,000 characters, and contains detailed financial and operational data about the use of capital raised by the company. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not an announcement of a report but the report itself, and it is not an annual or interim financial report, nor an earnings release or other category. Therefore, the best fit is CAP.
2015-08-27 Chinese
2015年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2015 年半年度报告摘要' which translates to '2015 Semi-Annual Report Summary'. It contains detailed financial data for the first half of 2015, including balance sheet items, income statement figures, cash flow data, shareholder information, management discussion and analysis, segment revenue breakdowns, investment and financing activities, and use of raised funds. The length is substantial (15,000 characters) and the content includes actual financial statements and substantive financial analysis for a period shorter than a full fiscal year (half-year). This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report (10-K). Therefore, the correct classification is IR with high confidence. H1 2015
2015-08-27 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.